Cargando…
Does race/ethnicity influence the impact of new glucose-lowering agents on cardiovascular outcomes?—a comparison between Asian versus White patients
Autor principal: | Scheen, André J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843340/ https://www.ncbi.nlm.nih.gov/pubmed/36660673 http://dx.doi.org/10.21037/atm-2022-54 |
Ejemplares similares
-
Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors
por: Scheen, André J.
Publicado: (2018) -
The association between Asian patient race/ethnicity and lower satisfaction scores
por: Liao, Lillian, et al.
Publicado: (2020) -
SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients
por: Scheen, André J
Publicado: (2020) -
New race and ethnicity standards: elucidating health disparities in diabetes
por: Katzmarzyk, Peter T, et al.
Publicado: (2012) -
Participatory Approaches to Addressing Missing COVID-19 Race and Ethnicity Data
por: Kader, Farah, et al.
Publicado: (2021)